5th Öresund Peptide Symposium
On September 24th, the Öresund Peptide Symposium is returning for its 5th edition with highlights and insights from the peptide community.
This year’s symposium is focusing on one of the hot topics of today’s pharmaceutical industry research – peptides and macrocycles in drug discovery – with experiences from both early and late stages of the drug development process. With contributions from market-leading companies and individuals from industry and academia we bring a highly valuable event to you.
Academic presentations will be held by keynote speaker Prof. Jan Kihlberg from Uppsala University (Sweden) and Prof. Fernando Albericio from the University of KwaZulu-Natal (South Africa). Leading companies such as Zealand Pharma, AstraZeneca, Gubra, Camurus, and others will contribute with valuable industry insights and real-world experiences.
Agenda
08:30 – 09:15 | Registration
09:15 – 09:30 | Welcoming by RG Discovery and Medicon Village
09:30 – 10:15 | Macrocycles in drug discovery – Target binding, solubility and cell permeability, Jan Kihlberg, Professor for Organic Chemistry at Uppsala University
10:15 – 10:45 | Coffee break/networking
10:45 – 11:10 | Next steps for de novo designed peptide therapeutics, Mads Mørup Nygaard, Senior Department Manager at Gubra, Computational Drug Discovery
11:10 – 11:45 | Peptide avatars in drug discovery. Ranganath Gopalakrishnan, Senior Director/Senior Principal Scientist at Zealand Pharma, Medicinal & Computational Chemistry
&
Peptide Drug Discovery; Challenges and opportunities in the time of AI, Christina Schröder, Director at Astra Zeneca, Peptide Chemistry, Hit Discovery, Discovery Sciences
11:45 – 12:10 | New tools for optimizing peptide syntheses, Fabien Rousset, Global Director Innovation at PolyPeptide
12:10 – 13:10 | Lunch break
13:10 – 13:55 | Building the Peptide Golden Era: Smarter, Greener and Scalable Synthesis, Fernando Alberico, Research Professor at the University of KwaZulu-Natal/Emeritus Professor at the University of Barcelona
13:55 -14:10 | Sponsor talk: Assay to Aggregates: Chromatographic Workflows for Therapeutic Peptides and Their Unique Impurities, Anders Franzén, Senior Technical Sales Consultant at Phenomenex
14:10 – 14:35 | TCP-25: An Immunomodulatory Peptide in Phase 2/3 Development for Dysregulated Inflammation in Epidermolysis Bullosa Wounds, Christian Kjellman, Chief Scientific Officer at Xinnate
14:35 – 15:05 | Coffee break/networking
15:05 – 15:30 | Development and stability of a heat‐stable carbetocin formulation, Mattias Malm, Senior Scientist at Ferring Pharmaceuticals
15:30 – 15:55 | Self-assembling lipid formulations for long-acting injections of peptides, Tomas Kjellman, Senior Scientist at Camurus
15:55 – 16:05 | Wrap-up
The registration for the event is open from 25th of May until 4th of September and currently there is a waiting list.
We are looking forward to seeing you all!